mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.004 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.004 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.005 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.006 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.006 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.007 |